Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11679143
FGF21 variant, fusion protein and application thereof
granted -
US 11679159
Compositions for transfecting resistant cell types
granted -
US 11666547
Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)
granted -
US 11666602
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
granted -
US 11667890
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
granted -
US 11661601
Methods for modulating FMR1 expression
granted -
US 11649207
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11642390
Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
granted -
US 11639504
Methods and compositions for regulation of transgene expression
granted -
US 11638708
Method of treatment of aggression
granted -
US 11634711
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 11633483
Modulators of PCSK9 expression
granted -
US 11629146
Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity
granted -
US 11629349
RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use
granted -
WO 2023054310
ENSEMBLE DE PERFUSION GOUTTE-À-GOUTTE INTRAVEINEUX POURVU D'UN FILTRE DE PERFUSION À ÉVENT D'AIR
granted -
US 11613752
Compositions and methods for modulating PKK expression
granted -
US 11607412
Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
granted -
US 11602559
HIV-1 Env fusion peptide immunogens and their use
granted -
CA 3230406
UTILISATION DE MICRO-ARN POUR LA REGULATION NEGATIVE DE L'EXPRESSION DE TRANSGENES CYTOTOXIQUES PAR LE VIRUS DE LA VACCINE ANKARA MODIFIE (MVA)
granted -
US 11596671
Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression
granted -
US 11590179
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
granted -
US 11583548
Compounds and methods for reducing ATXN3 expression
granted -
US 11572575
Compositions for transfecting resistant cell types
granted -
US 11572413
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted